Target engagement in a head-to-head clinical trial of dysphoric versus anxiosomatic transcranial magnetic stimulation targets.

Providing evidence-based psychiatric care and advanced TMS therapy for adults experiencing depression, anxiety, and treatment-resistant mood disorders.